Advertisement
Screener

Vincerx Pharma, Inc. Operating Expenses

Vincerx Pharma, Inc. Operating Expenses

Vincerx Pharma, Inc. reported Operating Expenses of $3.33 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2025-05-15

  • Vincerx Pharma, Inc. operating expenses for the quarter ending 2025-03-31 was $3.33M, a 55.42% decline year-over-year.
  • Vincerx Pharma, Inc. operating expenses for the quarter ending 2024-12-31 was $8.83M, a 59.52% increase year-over-year.
  • Vincerx Pharma, Inc. operating expenses for the quarter ending 2024-09-30 was $7.79M, a 18.90% decline year-over-year.
  • Vincerx Pharma, Inc. operating expenses for the quarter ending 2024-06-30 was $7.37M, a 38.92% decline year-over-year.
  • Vincerx Pharma, Inc. operating expenses for fiscal 2024 was $31.46M, a 26.16% decline from fiscal 2023.
  • Vincerx Pharma, Inc. operating expenses for fiscal 2023 was $42.61M, a 40.15% decline from fiscal 2022.
  • Vincerx Pharma, Inc. operating expenses for fiscal 2022 was $71.19M, a 13.62% increase from fiscal 2021.
  • Vincerx Pharma, Inc. operating expenses for fiscal 2021 was $62.66M, a 484.80% increase from fiscal 2020.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 10 monthOperating Expenses 12 monthOperating Expenses 12 month as first filed
2025-03-31$3.33M
10-Q · filed 2025-05-15
$12.16M
derived: sum of 2 quarters · filed 2025-05-15
$19.95M
derived: sum of 3 quarters · filed 2025-05-15
$27.32M
derived: sum of 4 quarters · filed 2025-05-15
2024-12-31$8.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$16.62M
derived: sum of 2 quarters · filed 2025-03-27
$23.98M
derived: sum of 3 quarters · filed 2025-03-27
$31.46M
10-K · filed 2025-03-27
2024-09-30$7.79M
10-Q · filed 2024-11-12
$15.16M
derived: sum of 2 quarters · filed 2024-11-12
$22.64M
10-Q · filed 2024-11-12
$28.17M
derived: sum of 4 quarters · filed 2025-05-15
2024-06-30$7.37M
10-Q · filed 2024-08-08
$14.84M
10-Q · filed 2024-08-08
$20.38M
derived: sum of 3 quarters · filed 2025-05-15
$29.99M
derived: sum of 4 quarters · filed 2025-05-15
2024-03-31$7.48M
10-Q · filed 2025-05-15
$13.01M
derived: sum of 2 quarters · filed 2025-05-15
$22.62M
derived: sum of 3 quarters · filed 2025-05-15
$34.68M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$5.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$15.14M
derived: sum of 2 quarters · filed 2025-03-27
$27.20M
derived: sum of 3 quarters · filed 2025-03-27
$42.61M
10-K · filed 2025-03-27
2023-09-30$9.61M
10-Q · filed 2024-11-12
$10.32M
10-Q · filed 2023-11-14
$21.67M
derived: sum of 2 quarters · filed 2024-11-12
$37.08M
10-Q · filed 2024-11-12
$50.12M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$12.06M
10-Q · filed 2024-08-08
$11.66M
10-Q · filed 2023-08-07
$27.47M
10-Q · filed 2024-08-08
$26.76M
10-Q · filed 2023-08-07
$40.51M
derived: sum of 3 quarters · filed 2024-08-08
$57.41M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$15.41M
10-Q · filed 2024-05-14
$15.10M
10-Q · filed 2023-05-11
$28.45M
derived: sum of 2 quarters · filed 2024-05-14
$45.35M
derived: sum of 3 quarters · filed 2024-05-14
$64.97M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$13.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$29.94M
derived: sum of 2 quarters · filed 2024-03-29
$49.56M
derived: sum of 3 quarters · filed 2024-03-29
$71.19M
10-K · filed 2024-03-29
$73.57M
10-K · filed 2023-03-28
2022-09-30$16.90M
10-Q · filed 2023-11-14
$36.52M
derived: sum of 2 quarters · filed 2023-11-14
$58.15M
10-Q · filed 2023-11-14
$75.86M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$19.62M
10-Q · filed 2023-08-07
$41.25M
10-Q · filed 2023-08-07
$58.96M
derived: sum of 3 quarters · filed 2023-08-07
$76.89M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$21.63M
10-Q · filed 2023-05-11
$39.33M
derived: sum of 2 quarters · filed 2023-05-11
$57.27M
derived: sum of 3 quarters · filed 2023-05-11
$74.66M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$17.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$35.64M
derived: sum of 2 quarters · filed 2023-03-28
$53.03M
derived: sum of 3 quarters · filed 2023-03-28
$62.66M
10-K · filed 2023-03-28
2021-09-30$17.93M
10-Q · filed 2022-11-10
$35.32M
derived: sum of 2 quarters · filed 2022-11-10
$44.95M
10-Q · filed 2022-11-10
$55.32M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$17.39M
10-Q · filed 2022-08-11
$27.02M
10-Q · filed 2022-08-11
$37.39M
derived: sum of 3 quarters · filed 2022-08-11
$37.70M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$9.63M
10-Q · filed 2022-05-12
$20.00M
derived: sum of 2 quarters · filed 2022-05-12
$20.30M
derived: sum of 3 quarters · filed 2022-05-12
$20.34M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$10.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$10.68M
derived: sum of 2 quarters · filed 2022-03-29
$10.71M
derived: sum of 3 quarters · filed 2022-03-29
$10.71M
10-K · filed 2022-03-29
2020-09-30$305.00K
10-Q · filed 2021-11-12
$440.39K
10-Q · filed 2020-11-10
$338.00K
derived: sum of 2 quarters · filed 2021-11-12
$342.00K
10-Q · filed 2021-11-12
2020-06-30$33.00K
10-Q · filed 2021-08-12
$37.00K
10-Q · filed 2021-08-12
$173.00K
10-K · filed 2020-09-23
2020-03-31$4.00K
10-Q · filed 2021-05-17
$38.59K
10-Q · filed 2020-05-06
$39.12K
10-Q · filed 2020-05-06
2019-12-31$45.00K
10-K/A · filed 2021-05-14
2019-09-30$100.00
10-Q · filed 2020-11-10
$100.00
derived: sum of 2 quarters · filed 2020-11-10
$1.55K
derived: sum of 3 quarters · filed 2020-11-10
2019-06-30$0.00
derived: 10-K 6 month − 10-Q 3 month · filed 2020-09-23
$1.45K
10-K · filed 2020-09-23
2019-03-31$1.45K
10-Q · filed 2020-05-06